About | Free Trial

Last Update

2005-10-12T00:00:00.000Z

This profile was last updated on . .

Is this you? Claim your profile.

Background Information

Employment History

Surgeon With the Diabetic Foot Unit
Abano Terme Hospital

Chief Diabetic Professor
Foot & Ankle Clinic

Web References (9 Total References)


Post-Approval

genetown.biospace.com [cached]

$reference.text


Oculus Innovative Sciences ...

www.fdanews.com [cached]

Oculus Innovative Sciences announced that Luca Dalla Paola, a surgeon with the diabetic foot unit of the Abano Terme Hospital in Italy, recently presented the results of a 218-patient controlled clinical study that assessed the safety and efficacy of Microcyn Technology in treating diabetic foot ulcers as compared to povidone iodine (10%) antiseptic, which is often used as the "standard care" in treatment of open wounds.


Infection Control Today - Results of a Clinical Study Evaluating Treatment of Diabetic Foot Ulcers Using Microcyn Technology Presented at Wound Management Conference

www.infectioncontroltoday.com [cached]

STUTTGART, Germany -- Oculus Innovative Sciences, Inc. announces that Dr. Luca Dalla Paola, a surgeon with the diabetic foot unit of the Abano Terme Hospital in Italy, recently presented the results of a 218-patient controlled clinical study that assessed the safety and efficacy of Microcyn technology in treating diabetic foot ulcers as compared to povidone iodine (10 percent) antiseptic, which is often used as the "standard care" in treatment of open wounds.


RESULTS OF CLINICAL STUDY EVALUATING TREATMENT OF DIABETIC FOOT ULCERS USING MICROCYN™ TECHNOLOGY PRESENTED AT STUTTGART2005

www.oculusis.com [cached]

STUTTGART, GERMANY-- (October 4, 2005)- Oculus Innovative Sciences, Inc. announced that Dr. Luca Dalla Paola, a surgeon with the diabetic foot unit of the Abano Terme Hospital in Italy, recently presented the results of a 218-patient controlled clinical study that assessed the safety and efficacy of Microcyn® Technology in treating diabetic foot ulcers as compared to povidone iodine (10%) antiseptic, which is often used as the "standard care" in treatment of open wounds.


STUTTGART, GERMANY-- (October 4, 2005)- ...

www.oculusis.com [cached]

STUTTGART, GERMANY-- (October 4, 2005)- Oculus Innovative Sciences, Inc. announced that Dr. Luca Dalla Paola, a surgeon with the diabetic foot unit of the Abano Terme Hospital in Italy, recently presented the results of a 218-patient controlled clinical study that assessed the safety and efficacy of Microcyn® Technology in treating diabetic foot ulcers as compared to povidone iodine (10%) antiseptic, which is often used as the "standard care" in treatment of open wounds.

Similar Profiles

Other People with this Name

Other people with the name Paola

Cristiana Di Paola
Saras S.p.A.

Manini Paola
European Commission

Ashley De Paola
Alliant Insurance Services Inc

Anthony De Paola
Kiehl

Paul Paola
Plomberium Pierrefonds

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory